(Q24186656)

English

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults

scientific article published in April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

0 references

1 reference

Europe PubMed Central

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults (English)

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

0 references

0 references

1 reference

based on heuristic

inferred from title

serotonin–norepinephrine reuptake inhibitor

1 reference

based on heuristic

inferred from title

6

0 references

1

0 references

author name string

Cristina Cusi

2

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Concetta Randazzo

3

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Roberto Sterzi

4

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Dario Tedesco

5

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

publication date

1 April 2015

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Cochrane Database of Systematic Reviews

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

4

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

CD002919

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Fluoxetine prophylaxis of migraine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

The efficacy and safety of venlafaxine in the prophylaxis of migraine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Paroxetine in the treatment of chronic daily headache.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Double-blind trial of fluoxetine: chronic daily headache and migraine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Randomisation and baseline comparisons in clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Psychiatric comorbidities of episodic and chronic migraine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Economic and social impact of migraine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Going from evidence to recommendations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Serotonin and migraine: biology and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Emerging targets in migraine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Pragmatic randomised controlled trials in psychiatry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Burden of migraine in the United States: disability and economic costs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

The International Classification of Headache Disorders, 3rd edition (beta version)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Tricyclic antidepressants and headaches: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

The cost of headache disorders in Europe: the Eurolight project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Is migraine a progressive brain disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Migraine prevalence, disease burden, and the need for preventive therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Global prevalence of chronic migraine: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Pharmacologic treatment of pain in polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Pharmacologic management of acute attacks of migraine and prevention of migraine headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Migraine pathogenesis and state of pharmacological treatment options

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Migraine: the seventh disabler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Content and quality of 2000 controlled trials in schizophrenia over 50 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Treatment of chronic headache with antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Migraine and reduced work performance: a population-based diary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Developing core outcome sets for clinical trials: issues to consider

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Analgesic overuse among subjects with headache, neck, and low-back pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

21 January 2018

Canadian Headache Society guideline for migraine prophylaxis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective serotonin reuptake inhibitors for migraine prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine for migraine prophylaxis: a double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of daily and near-daily headaches: field trial of revised IHS criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic frequent headache in the general population: prevalence and associated factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Classification of Headache Disorders: 2nd edition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of fluoxetine in the treatment of headache

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Headache assessment and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches

1 reference

https://pubmed.ncbi.nlm.nih.gov/25829028

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EHMTI-0031. Efficacy and safety of venlafaxine for the treatment of chronic migraine: a randomized, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002919.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD002919.PUB3

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

release_b2pxb5xncnfs3fepjhixd2suua

1 reference

https://api.fatcat.wiki/v0/release/b2pxb5xncnfs3fepjhixd2suua

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

1 reference

Europe PubMed Central

1 July 2019

http://europepmc.org/abstract/PMC/6513227

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24186656&oldid=1842199242"